UNITED STATES SECURITIES AND EXCHANGE COMMISSION
FORM 4 Washington, D. C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the
Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
( ) Check here if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
- ------------------------------------------------------------------------------------------------------------------------------------
|1 Name and Address of Reporting Person * |2 Issuer Name and Ticker/Trading Symbol|6 Relationship of Reporting |
| | | Person(s) to Issuer |
| Barnett Dana G |Mylan Laboratories Inc. MYL | (Check All Applicable) |
| |---------------------------------------| ( X ) Director ( ) 10% Owner |
| (Last) (First) (Middle) |3 IRS Identifica-|4 Statement for | ( X ) Officer ( ) Other |
| | tion Number of | Month/Year | (Give Title below) (Specify below) |
| 318 4th Avenue N. | Reporting | | |
| (Street 1) | Person, if | 06/01/2000 | Excutive Vice President |
| | an entity |---------------------|------------------------------------|
| | (Voluntary) |5 If Amendment, |7 Individual or Joint/Group Filing |
| (Street 2) | | Date of Original | (Check Applicable) |
| | ###-##-#### | (Month/Year) | Form filed by: |
| Tierra Verde FL 33715 | | | (X) One Reporting Person |
| (City) (State) (Zip) | | | ( ) One Reporting Person |
- ------------------------------------------------------------------------------------------------------------------------------------
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
- ------------------------------------------------------------------------------------------------------------------------------------
|1 Title of Security |2 Trans- |3 Trans- |4 Securities Acquired |5 Amount of |6 Ownership|7 Nature of Indirect |
| (Instruction 3) | action | action | (A) or Disposed of (D) | Securities | Form: | Beneficial Ownership |
| | Date | Code | (Instructions 3, 4, 5) | Beneficially | Direct(D) | (Instruction 4) |
| | (Month/ | (Instr 8)|------------------------| Owned at | or | |
| | Day) |----------| Amount |(A)| Price | End of Month |Indirect(I)| |
| | Year) | Code | V | |(D)| |(Instrs 3, 4) | (Instr 4) | |
|--------------------------------|---------|------|---|-----------|---|--------|--------------|-----------|------------------------|
| Mylan Laboratories Inc. Common | 06/14/00| P | | 2,000 | A | $17.75| 85,972 | D | |
| Stock | | | | | | | | | |
- ------------------------------------------------------------------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v). SEC 1474 (3-99)
FORM 4 (Continued)
- ------------------------------------------------------------------------------------------------------------------------------------
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(Puts, Calls, Warrants, Options, Convertible Securities)
- ------------------------------------------------------------------------------------------------------------------------------------
|1 Title of |2 Con- |3 Trans-|4 Trans-|5 Number of |6 Date |7 Title and Amount|8 Price |9 Number|10 Own-|11 Nature|
| Derivative | version| action | action | Derivative | Exercisable and | of Underlying | of |of Deri-|ership:| of |
| Security | or | Date | Code | Securities | Expiration Date | Securities | Deri- |vative |Direct |Indirect |
| (Instr 3) | Exer- | (Month/| (Instr | Acquired (A) or | (Month/Day/Year)|(Instructions 3,4)| vative |Securi- |(D) or |Ownership|
| | cise | Day/ | 8) | Disposed of (D) |-----------------|------------------| Sec- |ties |Indi- |(Instr 4)|
| | Price | Year) | |(Instrs 3, 4, 5) | Date | Expir- | |Amount | urity |Owned at|rect(I)| |
| | | |--------|-----------------| Exer- | ation | Title |or Num- |(Instr |End of |(Instr | |
| | | |Code| V | (A) | (D) | cisable| Date | |ber of | 5) |Month | 4) | |
| | | | | | | | | | |Shares | |(Instr4)| | |
|------------|--------|--------|----|---|--------|--------|--------|--------|---------|--------|--------|--------|-------|---------|
| NONE | | | | | | | | | | | | 230,000| D | |
- ------------------------------------------------------------------------------------------------------------------------------------
Explanation of Responses:
* Reporter has the "right to buy" 230,000 shares pursuant to the Issuers Stock Option Plan at exercise prices ranging from
$12.00 to $17.75.
Dana G Barnett Jul 5, 2000
____________________________________________ ____________
** Signature of Reporting Person Date
** Intentional misstatement or ommissions of facts constitute Federal Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: Transmit one copy of this Form to EDGAR, using a typed signature.
If space is insufficient, see Intruction 6 for procedure. SEC 1474 (3-99)
